Article
Effectiviness of neuraminidase inhibitors in reducing mortality in hospitalized influenza A (H1N1)pdm09 patients: an individual participant data meta-analysys
Registro en:
MUTHURI, Stella G. et al. Effectiviness of Neuraminidase inhibitors in reducing mortality in hospitalised Influenza A (H1N1)pdm09 patientss: an individual participant data meta-analysis. The Lancet Respiratory Medicine, v.2, n.5, p.395-404, May 2014.
2213-2600
10.1016/S2213-2600(14)70041-4
2213-2619
Autor
Siqueira, Marilda Agudo Mendonça Teixeira de
Múltipla autoria - ver em Notas
Resumen
Front author affiliations can be found on pp 25-29
†List of PRIDE Consortium Investigators’ can be found on pages 20, and affiliations listed in appendix pp 1-6 Neuraminidase inhibitors were widely used during the 2009–10 influenza A H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a meta-analysis of individual participant data to investigate the association between use of neuraminidase inhibitors and mortality in patients admitted to hospital with pandemic influenza A H1N1pdm09 virus infection. 2030-01-01